Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
BIOMARKER:
CCND1 amplification
i
Other names:
CCND1, BCL1, D11S287E, PRAD1, U21B31, Cyclin D1
Associations
(10)
News
Trials
B | Sensitive
C3 | Sensitive
C4 | Sensitive
D | Sensitive
B | Resistant
C3 | Resistant
C4 | Resistant
D | Resistant
Show legend
Include preclinical:
Drug categories
Tyrosine Kinase Inhibitors
Serine-Threonine Kinase Inhibitors
Cyclin Dependent Kinase Inhibitors
CD Protein Inhibitors
Immunotherapy
Hormone Therapy
Immune Checkpoint Inhibitors
EGFR
Cancel
Melanoma
Lung Non-Small Cell Squamous Cancer
Head and Neck Cancer
Squamous Cell Carcinoma of Head and Neck
Estrogen Receptor Positive Breast Cancer
Breast Cancer
Solid Tumor
sorafenib
B
CCND1 amplification
|
Melanoma
|
sorafenib
palbociclib
C3
CCND1 amplification
|
Lung Non-Small Cell Squamous Cancer
|
palbociclib
C3
CCND1 amplification
|
Estrogen Receptor Positive Breast Cancer
|
palbociclib
ribociclib
C3
CCND1 amplification
|
Melanoma
|
ribociclib
cetuximab + palbociclib
C3
CCND1 amplification
|
Head and Neck Cancer
|
cetuximab + palbociclib
cetuximab
C4
CCND1 amplification
|
Squamous Cell Carcinoma of Head and Neck
|
cetuximab
toripalimab-tpzi
C3
CCND1 amplification
|
Melanoma
|
toripalimab-tpzi
lapatinib
D
CCND1 amplification
|
Breast Cancer
|
lapatinib
Aromatase inhibitor
C3
CCND1 amplification
|
Breast Cancer
|
Aromatase inhibitor
Immunotherapy
C3
CCND1 amplification
|
Solid Tumor
|
Immunotherapy
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
